Position in VTRS
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$9,004,455
+$706,493 QoQ
Shares Held
666,503
0.0% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DekaBank Deutsche Girozentrale holds $123,990,883 across 10 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
93,532 | $55,462,604 | |
| 2 | ZTS |
Zoetis Inc.
|
332,878 | $39,349,508 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
115,973 | $15,278,282 | |
| 4 | VTRS |
Viatris Inc
This page
|
666,503 | $9,004,455 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
73,580 | $2,216,229 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
22,200 | $1,147,518 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
73,765 | $702,242 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
27,515 | $621,839 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,004,455 | 666,503 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $8,297,962 | 666,503 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $6,598,379 | 666,503 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $5,951,871 | 666,503 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $5,678,066 | 651,902 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $8,297,962 | 666,503 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $7,738,099 | 666,503 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $7,169,647 | 674,473 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $7,783,709 | 651,902 | Shares | Defined | 2024-06-04 | |
| 2023-12-31 | $6,917,175 | 638,705 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $6,261,109 | 635,001 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,529,534 | 654,262 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $6,091,172 | 633,178 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $7,050,820 | 633,497 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $3,256,190 | 382,182 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $3,909,581 | 373,408 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $1,979,844 | 181,971 | Shares | Defined | 2022-04-28 | |
| 2021-12-31 | $2,141,121 | 158,250 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $3,905,177 | 288,205 | Shares | Defined | 2021-10-22 | |
| 2021-06-30 | $4,836,693 | 338,467 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $4,824,119 | 345,320 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $14,307,576 | 763,478 | Shares | Defined | 2021-03-12 | |
| No filing history on record for this holder in this stock. | ||||||